Sonoma Pharmaceuticals, Inc.·4

Jan 3, 5:02 PM ET

Trombly Amy Moss 4

4 · Sonoma Pharmaceuticals, Inc. · Filed Jan 3, 2025

Insider Transaction Report

Form 4
Period: 2025-01-02
Trombly Amy Moss
Chief Executive Officer
Transactions
  • Award

    Restricted Stock Units

    2025-01-02+10,00018,685 total
    Exercise: $0.00Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock.
  • [F2]The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control.
  • [F3]The RSUs were awarded and granted to Ms. Trombly for services performed as part of the Company's annual equity grant.

Documents

1 file
  • 4
    ownership.xmlPrimary